Androgen deprivation therapy

Androgen deprivation therapy (ADT), a treatment for prostate cancer that reduces the production or effect of androgen hormones, eg. testosterone, which many prostate cancers depend on.[1] The side-effects make it controversial in some cases.[2] There is an increased risk of osteoporosis,[3] and possibly cardiovascular disease.[4]

See Management_of_prostate_cancer#Hormonal_therapy.

Further reading

References

  1. ^ Perlmutter and Lepor (2007). Androgen Deprivation Therapy in the Treatment of Advanced Prostate Cancer. PMC 1831539. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=1831539. 
  2. ^ "Overused: Androgen-Deprivation Therapy in Prostate Cancer". 2009. http://www.medscape.com/viewarticle/704292. 
  3. ^ "Use of Androgen Deprivation Therapy Increases Fracture Risk Among Prostate Cancer Patients, Study Finds". 2010. http://www.sciencedaily.com/releases/2010/11/101109183254.htm. 
  4. ^ Levine et al. (2010). Androgen-Deprivation Therapy in Prostate Cancer and Cardiovascular Risk. http://caonline.amcancersoc.org/cgi/content/full/60/3/194.